IL-34 and CSF-1 levels are altered in several chronic inflammatory diseases, including periodontitis, rheumatoid arthritis and inflammatory bowel disease, making them interesting candidates as potential therapeutic targets or biomarkers of disease [11–13]. This evidence concerns the gene CSF1 and periodontitis.